Stokes Family Office, LLC Abb Vie Inc. Transaction History

Stokes Family Office, LLC

$883 Million
Q3 2024

A detailed history of Stokes Family Office, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stokes Family Office, LLC holds 24,035 shares of ABBV stock, worth $4.13 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

24,035

Previous 23,826 0.88%

Holding current value

$4.13 Million

Previous $4.09 Million 16.15%

% of portfolio

0.54%

Previous 0.49%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $34,242 - $41,659	209 Added 0.88%	24,035 $4.75 Million
Q2 2024 Jul 05, 2024	BUY	$154.79 - $180.76 $78,014 - $91,103	504 Added 2.16%	23,826 $4.09 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $78,311 - $89,229	-490 Reduced 2.06%	23,322 $4.25 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $503,203 - $566,725	-3,657 Reduced 13.31%	23,812 $3.69 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $15,496 - $17,939	116 Added 0.42%	27,469 $4.09 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $6,758 - $8,409	51 Added 0.19%	27,353 $3.69 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $99,636 - $114,746	-689 Reduced 2.46%	27,302 $4.35 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $83,400 - $100,019	603 Added 2.2%	27,991 $4.53 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $51,134 - $58,647	381 Added 1.41%	27,388 $3.68 Million
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $11,422 - $14,521	-83 Reduced 0.31%	27,007 $4.14 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $70,081 - $86,951	531 Added 2.0%	27,090 $4.39 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $52,640 - $66,605	490 Added 1.88%	26,559 $3.6 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $13,619 - $15,459	-128 Reduced 0.49%	26,069 $2.81 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $31,036 - $34,576	295 Added 1.14%	26,197 $2.95 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $93,604 - $103,047	915 Added 3.66%	25,902 $2.8 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $40,969 - $55,313	509 Added 2.08%	24,987 $2.68 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $80,068 - $93,973	932 Added 3.96%	24,478 $2.14 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $62,584 - $83,747	853 Added 3.76%	23,546 $2.31 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $64 - $97	1 Added 0.0%	22,693 $1.73 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $1.64 Million - $2.05 Million	22,692 New	22,692 $2.01 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.

Account

Stokes Family Office, LLC Abb Vie Inc. Transaction History